Sanggenon O exhibits significant biological activity, making it valuable in pharmaceutical and biomedical research. It is studied for its anti-inflammatory properties, particularly in inhibiting key inflammatory mediators such as nitric oxide and prostaglandin E2. This compound also demonstrates neuroprotective effects, showing potential in the development of treatments for neurodegenerative disorders like Alzheimer’s disease by reducing oxidative stress and preventing neuronal cell damage. Additionally, Sanggenon O has been investigated for its anticancer activity, where it induces apoptosis and suppresses proliferation in certain cancer cell lines. Its antioxidant capacity further supports its use in formulations aimed at reducing cellular damage caused by free radicals. Due to these diverse activities, Sanggenon O is considered a lead compound in natural product-based drug discovery.